Latest news

Gene Regulation and Systems Biology now indexed by Pubmed

Journal newsletter sent to subscribers in week 37, 2009. Follow link to see newsletter summary.  Register to receive newsletters. 

Read an interview with author Dr Noburo Uchide

Journal newsletter sent to subscribers in week 35, 2009. Register to receive future newsletters. 

Read the Editor in Chief's latest call for papers here.

Journal newsletter sent to subscribers in week 32, 2009. Register to receive future newsletters.

This journal is now indexed by CABI Abstracts

Journal newsletter sent to subscribers in week 30, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 28, 2009. Register to receive future newsletters.

Journal newsletter sent to subscribers in week 26, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 20, 2009. Register to receive future newsletters.

Follow this journal on Twitter

Journal newsletter sent to subscribers in week 17, 2009.  Register to receive future newsletters.

Journal newsletter sent to subscribers in week 15, 2009.  Register to receive future newsletters. 

The journal has been accepted for indexing in EBSCO Academic Search Complete.

Journal newsletter sent to subscribers in week 12, 2009.  Register to receive future newsletters.

Journal newsletter sent to subscribers in week 11, 2009.  Register to receive future newsletters.

New call for papers sent to newsletter subscribers in week 10 2009.  Readers who wish to be elligible to receive CFPs should subscribe to the newsletter.

Journal newsletter sent to subscribers in week 9, 2009. Register to receive future newsletters.

Journal newsletter sent to subscribers in week 8, 2009. Register to receive future newsletters.

Read an interview with the Editor in Chief.

Journal overview

Aims and scope:

Gene Regulation and Systems Biology is concerned with the regulation of genes and the proteins they encode and the relationship between gene regulation and the wider field of systems biology.

The regulation of genes and the proteins they encode is at the core of systems biology. Understanding the role of gene regulation in the context of the entire system as it relates to disease processes will aid therapeutic development. Therefore, combining our knowledge of gene expression and promoter control, improving gene and protein networks, and determining the role of signal transduction will enhance our ability to treat complex diseases.

Systems biology is concerned with the integration of different levels of information to understand how complex biological systems function. By studying the relationships and interactions between various parts of a biological system (including gene and protein networks involved in cell signaling) it may be possible to create an understandable model of the whole system. Mathematical, analytic, and particularly computer simulation and heuristics are used as research methods.

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.

Indexing:

This journal is indexed by the following services:

• Pubmed
• Pubmed Central
  
• Embase
• Embiology
• Google Scholar
• CAS
• DOAJ
• Intute
• OAIster
  

SPARC Europe Seal award winner:

This journal has been awarded a SPARC Europe Seal. The Seal is an initiative of SPARC Europe (Scholarly Publishing and Academic Resources Coalition) and the Directory of Open Access Journals (DOAJ) which is awarded to journals applying a Creative Commons CC-BY copyright license and that make journal metadata accessible to DOAJ.  

Amongst other important services DOAJ makes metadata OAI-compliant.  This in turn enhances the visibility of papers and allows OAI-harvesters to include the details of journal articles in their services. We encourage readers to make use of this valuable resource.  The DOAJ search page is available here.

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 

Information for authors

Call for papers:

Read the Editor in Chief's latest call for papers here.

Submission types accepted:

• Original research articles.
• Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. They may cover basic science and clinical reviews, ethics, pro/con debates, and equipment reviews.
• Commentaries: focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue.
• Hypotheses: articles that present an original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
• Letters to the Editor: these can be either a re-analysis of a previously published article, or a response to such a re-analysis from the authors of the original publication.
• Methodology articles: these discuss a new experimental method, test or procedure. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
• Short reports: brief reports of data from original research.
• Meeting reports: a report pertaining to activity at a meeting or conference Articles published in this journal are immediately available without delay upon publication and enjoy substantial visibility.
• Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Case reports must meet appropriate ethical standards.

All submissions are subject to prompt, objective and fair peer review in compliance with our Fairness in Peer Review Policy.  Copyright in published articles remains with the author(s).  Authors are continually informed of the progress of their paper and our staff are friendly and responsive. 

One author recently wrote: "I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."

Criteria for publication: 

Publication is dependent on peer reviewers' judgement of papers.  Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility. 

Previous work in the field must be acknowledged and papers should read without unreasonable difficulty.  Papers should fit comfortably within the scope of the journal.

Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research.  They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible. 

More information on the role of peer reviewers is available on the information for reviewers page.  Where authors consider that reviewers have made recommendations which are unreasonable, unobjective or ill-founded they may appeal them to the Editor in Chief or Associate Editor under our Fairness in Peer Review Policy.

Articles submitted to other journals:

We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication. 

Services for authors:

Prior to peer review of your paper we can:

• Have your paper's reference style revised to meet our requirements,
• Have your paper's English revised by specialist English-speaking technical editors.

After peer review of your paper we can:

• Have your paper revised in accordance with peer reviewer's recommendations and have a summary of responses to the reviewers created by our specialist external substantive editors,
• Provide bound reprints of your article in colour or black and white ,
• 
  

Editor in Chief profile

Dr James Willey is Professor of Medicine and Pathology at the University of Toledo Medical Center, Toledo, OH. Dr Willey has participated in several national and international consortia comprising academic, governmental, and industrial groups aiming to improve quantification and standardization of transcript abundance measurement. His primary area of research is development of quantitative methods for transcript abundance measurement and quantitative analysis of the relationship between transcript abundance level, promoter DNA sequence, and functional status of proteins that interact with the promoter DNA sequence. His applied research involves applying this quantitative approach to understanding how a particular combination common inherited DNA variants in promoter regions and/or regulatory protein coding regions may increase risk for disease or alter individual response to therapeutics by decreasing optimal regulation of key genes responsible for the normal phenotype.

He is a Founder of Gene Express, Inc., located in Toledo, Ohio. Prior to joining the University of Toledo Medical Center and University of Toledo College of Medicine in 1994, Dr. Willey was Assistant Professor of Medicine and Environmental Medicine at the University of Rochester School of Medicine, Rochester, N.Y. He did his post-doctoral training at the National Cancer Institute with Curt Harris. He completed training in Pulmonary Medicine at University of Rochester Strong Memorial Hospital, and now focuses on diagnosis and treatment of lung cancer.

Read an interview with the Editor in Chief  here.

>> Dr Willey's latest call for papers

Editorial Board

David Arnosti, PhD
Associate Professor, Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA

Herbert L Bonkovsky, PhD
Professor of Medicine and Molecular, Microbial & Structural Biology Director, The Liver-Biliary-Pancreatic Center, University of Connecticut Health Center, Framington, CT, USA

Constance E Brinckerhoff, PhD
Professor of Medicine and Biochemistry, Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, NH, USA

George M Carman, PhD
Professor, Department of Food Science, Rutgers University, New Brunswick, NJ, USA

John Chiang, PhD
Professor, Biochemistry and Molecular Pathology, Northeastern Ohio University's College of Medicine, Rootstown, OH, USA

Gwen V Childs, PhD
Professor and Chair, Department of Neurobiology and Developmental Sciences, COllege of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Kwang-Hyun Cho, PhD
Professor, Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea

Vitaly Citovsky, PhD
Professor, Department of Biochemistry and Cell Biology, State University of New York, Stony Brook, NY, USA

Frederick E Domann, PhD
Professor of Radiation Oncology, Free Radical & Cancer Biology Program, Carver College of Medicine & The Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, USA

Robert Hitzemann, PhD
Professor and Chairman, Department of Behavioral Neuroscience, Oregon Health Sciences University, Portland, OR, USA

Jingfang Ju, PhD
Head, Cancer Genomics Laboratory, Assistant Professor of Pharmacology and Medicine USA-Mitchell Cancer Institute, Mobile, AL, USA

Timothy J Kinsella, MD
Vincent K Smith Professor and Chairman, Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, OH, USA

Lee Kroos, PhD
Professor and Associate Chair, Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA

David W Li, PhD
Associate Professor, Department of Biochemistry and Molecular Biology; Associate Professor (Courtesy Appointment) Department of Ophthalmology and Visual Science, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA

Jonathan D Licht, MD
Professor and Chief, Division of Hematology/Oncology; Associate Director, Clinical Sciences, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Horace H Loh, PhD
Frederick Stark Professor and Head Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA

Pamela L Mellon, PhD
Professor of Reproductive Medicine and Neuroscience Director, Center for Reproductive Science and Medicine, University of California, San Diego, School of Medicine, La Jolla, CA, USA

Manohar Ratnam, PhD
Professor, Medical University of Ohio, Toledo, OH, USA

Gene E Robinson, PhD
G William Arends Professor of Integrative Biology; Director, Neuroscience Program; Chair, Genomics of Neural and Behavioral Plasticity Theme, Institute for Genomic Biology, Department of Entomology, University of Illinois at Urbana-Champaign, Urbana, IL, USA

Mark Smith, PhD
Professor of Pathology Wolstein Research Building, Department of Pathology Case Western Reserve University, Cleveland, Ohio, USA

Bruce Tidor, PhD
Biomedical Engineering Division, Department of Electrical Engineering and Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, USA

Geoffrey M Wahl, MD, PhD
Professor, The Salk Institute, GEL-W, La Jolla, CA, USA

Li-Na Wei, PhD
Professor, Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, USA

Jane Wu, MD, PhD
Charles Louis Mix Professor of Neurology, Northwestern University Feinberg School of Medicine, Robert H Lurie Comprehensive Cancer Center, Center for Genetic Medicine, Chicago, IL, USA

Hiroki Yokota, PhD
Biomedical Engineering, and Anatomy & Cell Biology, Indiana University - Purdue University, Indianapolis, Indianapolis, IN, USA

Ming Zhan, PhD
Chief of Bioinformatics Unit, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA

Join an editorial board or update your details:

Related journals